Physician profile
David C Parris
NPI 1154403921
$2,489.35
in general payments reported to CMS, 2019-2025
35 companies · $302 in 2025
The $302 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $941 · 2020: $109 · 2021: $513 · 2022: $309 · 2023: $246 · 2024: $68.40 · 2025: $302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $617.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $617.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $450.09 | 2019-2025 | Gardasil 9, Vaxneuvance, Capvaxive |
| Novo Nordisk INC | $290.97 | 2019-2025 | Saxenda, Wegovy, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $232.97 | 2019-2022 | |
| Glaxosmithkline, LLC. | $189.42 | 2019-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $184.27 | 2019-2025 | Airsupra |
| Sunovion Pharmaceuticals INC. | $147.01 | 2019 | |
| Mannkind Corporation | $113.50 | 2020-2021 | |
| Abbvie INC. | $107.34 | 2019-2023 | |
| Lilly USA, LLC | $70.68 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Dynavax Technologies Corporation | $58.41 | 2022 | |
| Sanofi-Aventis U.S. LLC | $51.92 | 2019-2025 | |
| Otsuka America Pharmaceutical, INC. | $48.33 | 2025 | Rexulti |
| Teva Pharmaceuticals USA, INC. | $45.44 | 2019-2025 | Austedo Xr |
| Abbott Laboratories | $44.48 | 2020-2021 | |
| Amgen INC. | $39.47 | 2019 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $39.07 | 2022 | |
| Pfizer INC. | $38.14 | 2019-2023 | |
| Zealand Pharma US, INC. | $32.13 | 2021-2022 | |
| Amarin Pharma, INC. | $29.98 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.25 | 2019 | |
| Radius Health, INC. | $26.25 | 2019 | |
| Insulet Corporation | $25.59 | 2025 | Omnipod |
| Scilex Pharmaceuticals INC. | $20.64 | 2019 | |
| Hologic Sales and Service, LLC | $18.79 | 2022 | |
| Ucb, INC. | $18.03 | 2019 | |
| Sanofi Pasteur INC. | $16.72 | 2025 | |
| Mylan Specialty L.P. | $14.87 | 2019 | |
| Exact Sciences Corporation | $14.83 | 2023 | Cologuard Collection Kit |
| Melinta Therapeutics, LLC | $14.57 | 2019 | |
| Astellas Pharma US INC | $13.89 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.40 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.33 | 2021 | |
| Shionogi INC | $12.93 | 2019 | |
| Supernus Pharmaceuticals, INC. | $11.85 | 2019 | |
| Janssen Pharmaceuticals, INC | $10.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Parris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.